 Taysha Gene Therapies, Inc. NASDAQ:TSHA Q2 2022 Results Conference Call August 11, 2022 8:00 AM ET Company Participants Dr. Kimberly Lee - Chief Corporate Affairs Officer RA Session - President, Founder, and Chief Executive Officer Dr. Suyash Prasad - Chief Medical Officer and Head, RD Kamran Alam - Chief Financial Officer Dr. Frederick Porter - Chief Technical Officer Conference Call Participants Joon Lee - Jo Securities Gil Blum - Needham Company Mike Ulz - Morgan Stanley Eun Yang - Jefferies Jack Allen - Baird Yun Zhong - BTIG Sami Corwin - William Blair Rick Miller - Cantor Fitzgerald Operator Greetings. Welcome to the Taysha Gene Therapies Second Quarter 2022 Financial Results and Corporate Update Conference Call. 